The industry and its issues, from editor-in-chief Patrick Clinton.
October 1, 2009
Governments and payers don't see that innovation covers everything from invention to building market share. Scant attention is paid to the critical "back end" of the innovation cycle.
 |
September 1, 2009
Mastery of internal factors can mean the difference between thriving and failing in an environment where industry is a price taker, not a price setter.
|
August 1, 2009
Through innovative patient compliance programs, manufacturers are taking steps to meet the needs of patients and the pharma industry.
|
July 1, 2009
By:Patrick Clinton
In the long run, pharma wants to sell health, not just drugs.
|
June 1, 2009
By:Patrick Clinton
FDA slaps down Cheerios and forces pharma companies that use Google to make technical changes no consumer will ever notice. Big whoop.
|
May 1, 2009
By:Patrick Clinton
Our 3-D cover jumps off the page. But the real question for us (and for you) is how do we get everything else to connect?
|
April 1, 2009
By:Patrick Clinton
Unsolicited advice for FDA's next leader: Keep it real, fight popular delusions, and somehow, please, defend the agency.
|
March 1, 2009
By:Patrick Clinton
The worst thing about working for most corporations is the inevitable downward pull they exert even on the best of us. That's why it's always sad to lose a company that learned to fight back.
|
February 1, 2009
By:Patrick Clinton
No one who cares about global health can be happy with a system that only "eventually" delivers drugs and vaccines for the planet's neediest people
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?
Super Reps book trilogy by Dr. Lou Sawaya MD, MBA
Don't miss this Podcast series commemorating the 20th anniversary of HBA's Woman of the Year Award with interviews spanning two decades of change makers.
Conducting clinical trials in emerging regions can give you the edge. Five Quintiles experts share their insights into navigating the global regulatory landscape.